Keith John Herzog

Title: Keith John Herzog: Innovator in Pharmaceutical Compounds

Introduction

Keith John Herzog is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 5 patents, Herzog's work has had a meaningful impact on therapeutic practices.

Latest Patents

Herzog's latest patents include innovative compounds such as 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one and 5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for the alpha 7 nicotinic acetylcholine receptor. This invention encompasses nicotinic acetylcholine receptor reactive compounds that are useful in treating diseases and conditions. Additionally, he has developed compounds and methods for the treatment of overactive bladder, which are particularly beneficial for mammals, including humans.

Career Highlights

Throughout his career, Herzog has worked with prominent companies such as AstraZeneca AB and Zeneca Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.

Collaborations

Some of Herzog's notable coworkers include Thomas Michael Bare and James Roy Empfield. Their collaborative efforts have further enhanced the development of innovative pharmaceutical solutions.

Conclusion

Keith John Herzog is a distinguished inventor whose work in pharmaceutical compounds has paved the way for new treatments and therapies. His contributions continue to influence the medical field positively.